  
<prompt> IPTp 3+ Trends by Residence
 Percent of women age 15-49 with a live birth in the past two years who, during their last pregnancy, received atleast 3 or more doses of SP/Fansidar who received atleast one dose during an antenatal care visit. 
 [["", "EDSB-III 2006", "EDSB-IV 2011-2012", "EDSB-V 2017-2018"], ["Urban", 1, 11, 16], ["Rural", 1, 7, 12]] 
 <response> Coverage of IPTp 3+ is slightly higher in urban areas (16%) than in rural areas (12%).  